| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/29/2008 | US20080124714 Method for Stabilizing Biological Samples for Nucleic Acid Analysis |
| 05/29/2008 | US20080124445 introducing into proginator cells of the plant a plant transformation vector containing a nucleotide sequence that encodes or is complementary to a sequence that encodes a high meal quality or high oil quality polypeptide; transgenic plants; seed oil; increase in available metabolizable energy in meal |
| 05/29/2008 | US20080124444 Generation of Plants with Altered Oil Content |
| 05/29/2008 | US20080124427 Process for preparing a dough comprising a starch-degrading glucogenic exo-amy-lase of family 13 |
| 05/29/2008 | US20080124365 Using single-stranded DNA template to generate antisense RNA sequences for treatment and prevention of viral infection and cell proliferative disorders; viricides; antitumor agents |
| 05/29/2008 | US20080124364 Recombinant Plasmid and Method for Expressing Hepatitis B Viral Antigens and Virions in Vivo |
| 05/29/2008 | US20080124362 Domain II Mutants Of Anthrax Lethal Factor |
| 05/29/2008 | US20080124361 consisting essentially of: a flagellin adjuvant comprising, consisting of, or consisting essentially of a flagellin N-terminal constant region; a flagellin C-terminal constant region; and a Yersinia pestis antigen between the N-terminal constant region and the C-terminal constant region |
| 05/29/2008 | US20080124360 Adenovirus particles with enhanced infectivity of dendritic cells and particles with decreased infectivity of hepatocytes |
| 05/29/2008 | US20080124358 Chemically conjugating a peptide of interest to a heterologous peptide that has been expressed on the coat protein of a cowpea mosaic virus to generate a conjugate and administering the conjugate to a host animal to increase the level of TH1-type immune response |
| 05/29/2008 | US20080124357 vector may contain at least one heterologous nucleic acid molecule(s), expresses in vivo in the animal VSV antigen(s), immunogen(s) or epitope(s) thereof, e.g., VSV G protein and/or VSV N protein and/or VSV M protein |
| 05/29/2008 | US20080124353 Proteinase k resistant surface protein of neisseria meningitidis |
| 05/29/2008 | US20080124351 Proteinase k resistant surface protein of neisseria meningitidis |
| 05/29/2008 | US20080124347 Insulinotropic peptide conjugate using carrier substance |
| 05/29/2008 | US20080124346 Chimeric metal binding protein for use in prevention and treatment of cancer, diabetes, cardiovascular disease, obesity, metabolic disease, neurodegenerative disease, gastrointestinal disease, autoimmune disease, rheumatological disease and infectious disease. |
| 05/29/2008 | US20080124345 Human epidermal growth factor (HER) binding ligand for use in prevention and treatment of cell proliferative disorders |
| 05/29/2008 | US20080124339 Monoclonal antibody specific to mucosal addressin cell adhesion molecule (MAdCAM) for use in prevention and treatment of inflammatory, gastrointestinal, liver disorders |
| 05/29/2008 | US20080124337 Immunoglobulin for use in diagnosis, prevention and treatment of neisserial infection; immunootherapeutics |
| 05/29/2008 | US20080124336 Molecules and Methods for Inhibiting Shedding of KIM-1 |
| 05/29/2008 | US20080124335 Novel Polypeptide and the Use Thereof |
| 05/29/2008 | US20080124324 Immunoglobulin for use in treatment of inflammation, wound repair and tissue modeling |
| 05/29/2008 | US20080124322 Activation and inhibition of the immune system |
| 05/29/2008 | US20080124315 Method of reducing CRF receptor mRNA |
| 05/29/2008 | US20080124313 Nucleotide sequences coding methionyl tRNA synthetase protein for use in identifying modulators for prevention and treatment of bacterial infection |
| 05/29/2008 | US20080124310 Bead based receptor biology |
| 05/29/2008 | US20080124308 Gene Therapy of Solid Tumours by Means of Retroviral Vectors Pseudotyped With Arenavirus Glycoproteins |
| 05/29/2008 | US20080124305 Methods for isolating phage and for controlling microorganism populations with the phage |
| 05/29/2008 | US20080124304 Using vector transformation to generate cells which produce viral particle for use in medical genetics |
| 05/29/2008 | US20080124301 Oligonucleotide for use in prevention and treatment of cell proliferative and nervous system disorders; antisense agents |
| 05/29/2008 | US20080124284 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with Porphyromonas gingivalis |
| 05/29/2008 | US20080124277 Human and Mouse Targeting Peptides Identified by Phage Display |
| 05/29/2008 | DE102007041812A1 Einzelkettiger Pan-ecto-nox (SCFV)-Antikörper mit variabler Region, kodierende Sequenz sowie Verfahren Single chain Pan-ecto-nox (SCFV) antibody variable region coding sequence and methods |
| 05/29/2008 | DE102005031427B4 Programmierbare Vorrichtung und Verfahren zur Optimierung und Echtzeit-Überwachung der Gen-Transfektion auf der Basis einer benutzerkonfigurierten willkürlichen Wellenformimpulsfolge Programmable apparatus and method for optimizing, and real-time monitoring of gene transfection on the basis of a user-configured arbitrary waveform pulse sequence |
| 05/29/2008 | CA2683114A1 Cells expressing alpha-synuclein and uses therefor |
| 05/29/2008 | CA2681568A1 Oligonucleotides for modulating target rna activity |
| 05/29/2008 | CA2670446A1 Ilt-2 (liri) variants with increased affinity for mhc class i molecules |
| 05/29/2008 | CA2670389A1 Transgenic animal with enhanced immune response and method for the preparation thereof |
| 05/29/2008 | CA2670096A1 Biofuel production methods and compositions |
| 05/29/2008 | CA2670018A1 Lunaria annua, cardamine graeca and teesdalia nudicaulis fae genes and their use in producing nervonic and eicosenoic acids in seed oils |
| 05/29/2008 | CA2670003A1 Genetic ablation of the prp gene cells using a targeted promoter trap strategy for production of serum-free recombinant proteins as therapeuticals |
| 05/29/2008 | CA2669558A1 Compositions and methods related to toll-like receptor-3 |
| 05/29/2008 | CA2669275A1 Agent for inhibiting cytokinin signaling |
| 05/29/2008 | CA2668917A1 Enzyme for the production of long chain peracid |
| 05/29/2008 | CA2667705A1 Suppression of mitochondrial oxidative stress |
| 05/29/2008 | CA2665839A1 Polypeptide ligands for targeting cartilage and methods of use thereof |
| 05/29/2008 | CA2664987A1 Transgenic plants comprising as transgene a class i tcp or clavata 1 (clv1) or cah3 polypeptide having increased seed yield and a method for making the same |
| 05/29/2008 | CA2663768A1 Delta-8 desaturases and their use in making polyunsaturated fatty acids |
| 05/29/2008 | CA2609823A1 Sequencing of oligonucleotides by mass spectrometry |
| 05/28/2008 | EP1925941A1 Method for prediction of the efficacy of vascularization inhibitor |
| 05/28/2008 | EP1925678A1 Polynucleotide matrix-based method of identifying microorganisms |
| 05/28/2008 | EP1925677A2 Marker genes for determining renal toxicity |
| 05/28/2008 | EP1925675A1 Process for production of nucleoside compound |
| 05/28/2008 | EP1925672A1 Abiotic stress responsive polynucleotides and polypeptides |
| 05/28/2008 | EP1925671A1 Flax (Linum usitatissimum L.) seed-specific promoters |
| 05/28/2008 | EP1925670A1 Escherichia coli expression vector and the uses thereof |
| 05/28/2008 | EP1925669A1 Thermostable chimeric nucleic acid polymerases and uses thereof |
| 05/28/2008 | EP1925668A2 Genes involved in the biosynthesis of thiocoraline and heterologous production of same |
| 05/28/2008 | EP1925667A1 Specific protein of the pancreatic beta cells of the Langerhans' islands and its applications |
| 05/28/2008 | EP1925666A1 Human Toll-like receptor proteins, related reagents and methods |
| 05/28/2008 | EP1925665A1 Use of non-viral active agents manufactured with a molecular-biological method for treating acne |
| 05/28/2008 | EP1925664A1 Artificial binding proteins based on a modified alpha helical region of ubiquitin |
| 05/28/2008 | EP1925663A1 Two-steps enzyme method for preparing 7-aminocephalosporanic acid |
| 05/28/2008 | EP1925662A1 Recombinant Poxvirus-Cytomegalovirus Compositions and uses |
| 05/28/2008 | EP1925626A1 Novel multifunctional cytokines |
| 05/28/2008 | EP1925320A2 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics |
| 05/28/2008 | EP1925316A2 Compositions for treating vaginal, cervical and uterine epithelial lesions |
| 05/28/2008 | EP1924705A1 Isolation of cpg islands by thermal segregation and enzymatic selection-amplification method |
| 05/28/2008 | EP1924699A2 Aureobasidin a synthetase |
| 05/28/2008 | EP1924698A2 Ocular gene therapy using avalanche-mediated transfection |
| 05/28/2008 | EP1924697A2 Production of bone morphogenic proteins (bmps) in transgenic mammals |
| 05/28/2008 | EP1924696A2 Methods for genetic control of insect infestations in plants and compositions thereof |
| 05/28/2008 | EP1924695A2 Polynucleotides encoding carotenoid and apocarotenoid biosynthetic pathway |
| 05/28/2008 | EP1924694A1 Method for producing amino acids using micro-organisms |
| 05/28/2008 | EP1924693A1 Hybrid portable origin of replication plasmids |
| 05/28/2008 | EP1924692A2 Modulation of immunostimulatory properties of short interfering ribonucleic acid (sirna) by nucleotide modification |
| 05/28/2008 | EP1924691A1 Gene silencing of protease activated receptor 1 (par1) |
| 05/28/2008 | EP1924690A2 Methods for screening for compounds that modulate insulin promoter activity |
| 05/28/2008 | EP1924687A2 Alcohol acetyl transferase gene and use thereof |
| 05/28/2008 | EP1924605A1 Compositions and methods for diagnosing and treating an inflammation |
| 05/28/2008 | EP1924598A2 Esterase gene and use thereof |
| 05/28/2008 | EP1924288A2 Fully human hybridoma fusion partner cell lines |
| 05/28/2008 | EP1924283A1 Compositions comprising immunostimulatory rna oligonucleotides and methods for producing said rna oligonucleotides |
| 05/28/2008 | EP1924282A2 Immunization of avians by administration of non-replicating vectored vaccines |
| 05/28/2008 | EP1814895A4 Apparatus and system having dry control gene silencing compositions |
| 05/28/2008 | EP1765058A4 Nucleic acid molecules and their use in plant male sterility |
| 05/28/2008 | EP1765056A4 Markers for salinity tolerance in wheat plants and the use thereof in breeding programs |
| 05/28/2008 | EP1745155A4 Multiplexed detection of biological agents |
| 05/28/2008 | EP1727900A4 Method for selectively separating and purifying rna and method for separating and purifying nucleic acid |
| 05/28/2008 | EP1723417A4 C20orf23 as modifier of the igfr pathway and methods of use |
| 05/28/2008 | EP1723415A4 Pdes as modifiers of the igfr pathway and methods of use |
| 05/28/2008 | EP1723260A4 Nucleic acid representations utilizing type iib restriction endonuclease cleavage products |
| 05/28/2008 | EP1691792A4 Compositions and methods for in vitro sorting of molecular and cellular libraries |
| 05/28/2008 | EP1687438A4 Methods and compositions for altering seed phenotypes |
| 05/28/2008 | EP1670932A4 Libraries of recombinant chimeric proteins |
| 05/28/2008 | EP1651758B1 Method for producing l-lysine or l-threonine using escherichia bacteria having attenuated malic enzyme activity |
| 05/28/2008 | EP1641820B1 Rasgap derived peptide for selectively killing cancer cells |
| 05/28/2008 | EP1639083A4 Porcine cmp-n-acetylneuraminic acid hydroxylase gene |
| 05/28/2008 | EP1560840A4 Compositions comprising alternating 2'-modified nucleosides for use in gene modulation |
| 05/28/2008 | EP1543162B1 Method for sequencing reaction clean-up |
| 05/28/2008 | EP1537243B1 Method of diagnosing ovarian endometriosis |